These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Intravenous hyperalimentation for cancer chemotherapy]. Hioki K; Kojima Y; Boku T; Hiramatsu Y Nihon Rinsho; 1991 Nov; 49 Suppl():608-14. PubMed ID: 1798169 [No Abstract] [Full Text] [Related]
4. How to keep kidneys safe while shrinking tumors: the conundrum of cisplatin action. Goligorsky MS Am J Physiol Renal Physiol; 2007 Jul; 293(1):F50-1. PubMed ID: 17507601 [No Abstract] [Full Text] [Related]
5. [Determination of individual kidney function?]. Lipp HP Med Monatsschr Pharm; 2008 Oct; 31(10):393-5. PubMed ID: 18975414 [No Abstract] [Full Text] [Related]
6. Adverse effects of cytotoxics-platinum agents. Selvaratnam G; Philips RH; Mohamed AK; Radzi A Adverse Drug React Toxicol Rev; 1997 Aug; 16(3):171-97. PubMed ID: 9512763 [No Abstract] [Full Text] [Related]
7. [Gamma-glutamyltranspeptidase activity of the urine in the diagnosis of nephrotoxicity]. Dzhumabaeva FT; Pashintseva LP; Liubimova NV; Bassalik LS Lab Delo; 1988; (10):56-8. PubMed ID: 2462092 [No Abstract] [Full Text] [Related]
8. [Prevention and treatment of the side effects of cancer chemotherapy]. Iki S; Urabe A Gan To Kagaku Ryoho; 2000 Oct; 27(11):1635-40. PubMed ID: 11057312 [TBL] [Abstract][Full Text] [Related]
9. Current role of chemotherapy protectors in cancer treatment. Cáceres W; Báez L; Aponte I; Rodríguez N; Maldonado A Bol Asoc Med P R; 1997; 89(10-12):184-8. PubMed ID: 9577052 [TBL] [Abstract][Full Text] [Related]
10. Comparison of oral and intravenous hydration and diuretic, choice for protecting cisplatin induced nephrotoxicity. Dana R; Kachhwaha VS Indian J Cancer; 1996 Dec; 33(4):168-70. PubMed ID: 9254992 [TBL] [Abstract][Full Text] [Related]
12. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M; Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762 [TBL] [Abstract][Full Text] [Related]
13. [Management of Kidney Disease on Cancer Chemotherapy with Other Drugs than Platinum Agents]. Shimodaira H Gan To Kagaku Ryoho; 2017 Mar; 44(3):204-210. PubMed ID: 28292991 [TBL] [Abstract][Full Text] [Related]
14. [Side-effects of antineoplastic agents]. Kubo A Naika; 1968 Sep; 22(3):616-26. PubMed ID: 5708432 [No Abstract] [Full Text] [Related]